NCT03819647View on ClinicalTrials.gov

Evaluation of the Efficacy of Stiripentol (Diacomit) as Monotherapy for the Treatment of Primary Hyperoxaluria

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 21, 2019

Primary Completion Date

December 18, 2020

Study Completion Date

March 8, 2021

Conditions
Primary Hyperoxaluria
Interventions
DRUG

stiripentol (Diacomit)

Administration of stiripentol per os

Trial Locations (3)

Unknown

Hôpital Necker, Paris

Hôpital Robert Debré, Paris

Hôpital Tenon, Paris

Sponsors

Lead Sponsor

Biocodex
All Listed Sponsors
lead

Biocodex

INDUSTRY

NCT03819647 - Evaluation of the Efficacy of Stiripentol (Diacomit) as Monotherapy for the Treatment of Primary Hyperoxaluria | Biotech Hunter | Biotech Hunter